Search results
Moderna’s flu-COVID combo shot hits goal in late-stage trial - Indianapolis Business Journal
Indianapolis Business Journal· 4 days agoThe trial compared people who got Moderna’s combination vaccine with those who got both a...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 6 hours agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
New COVID Vaccines Targeting JN.1 Will Arrive This Fall
Verywell Health via Yahoo News· 6 days agoMorsa Images / Getty Images Fact checked by Nick BlackmerFact checked by Nick Blackmer Key Takeaways...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CNN.com· 6 days agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
Another COVID vaccine? Yes, and here’s why
Denver Post· 2 days agoVaccine manufacturers Pfizer and Moderna say they were prepared to make updated vaccines available in August, pending final FDA approval ...
Moderna's Combo Flu/Covid Shot Topped Rivals From Sanofi, GSK
Investor's Business Daily· 4 days agoIn a study of about 8,000 people, Moderna's combination vaccine proved it's not inferior to the...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation...
KION 46 Salinas· 6 days agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
CNN.com· 4 days agoCalling the outcome of the late-stage trial “breakthrough results,” Moderna’s Chief Medical Affairs...
New COVID variant emerges as ER visits rise in the US
Scripps News via AOL· 1 day agoUpdated data from the Centers for Disease Control and Prevention shows that a recent COVID-19...
COVID-flu combination vaccine shows positive results in late-stage trial, Moderna says
WPTZ Burlington· 3 days agoCalling the outcome of the late-stage trial “breakthrough results,” Moderna’s Chief Medical Affairs...